Growth Metrics

Organon (OGN) Gains from Investment Securities (2021 - 2026)

Organon has reported Gains from Investment Securities over the past 6 years, most recently at $1.0 million for Q1 2026.

  • For Q1 2026, Gains from Investment Securities changed 0.0% year-over-year to $1.0 million; the TTM value through Mar 2026 reached -$87.0 million, down 410.71%, while the annual FY2025 figure was -$87.0 million, 1352.16% down from the prior year.
  • Gains from Investment Securities for Q1 2026 was $1.0 million at Organon, up from -$27.0 million in the prior quarter.
  • Over five years, Gains from Investment Securities peaked at $41.0 million in Q4 2023 and troughed at -$73.0 million in Q3 2025.
  • A 5-year average of -$1.8 million and a median of $2.0 million in 2024 define the central range for Gains from Investment Securities.
  • Biggest five-year swings in Gains from Investment Securities: surged 720.0% in 2023 and later tumbled 3750.0% in 2025.
  • Year by year, Gains from Investment Securities stood at $5.0 million in 2022, then skyrocketed by 720.0% to $41.0 million in 2023, then plummeted by 90.24% to $4.0 million in 2024, then crashed by 775.0% to -$27.0 million in 2025, then skyrocketed by 103.7% to $1.0 million in 2026.
  • Business Quant data shows Gains from Investment Securities for OGN at $1.0 million in Q1 2026, -$27.0 million in Q4 2025, and -$73.0 million in Q3 2025.